(Prevention Regimen for Effectively Avoiding Second StrokesPRo FESS)trial内皮型一氧化氮合酶endothelial nitric oxide synthase(e NOS)内-中膜厚度intima-media thickness(IMT)凝血酶时间thrombin time(TT)凝血酶原时间prothromb...(Prevention Regimen for Effectively Avoiding Second StrokesPRo FESS)trial内皮型一氧化氮合酶endothelial nitric oxide synthase(e NOS)内-中膜厚度intima-media thickness(IMT)凝血酶时间thrombin time(TT)凝血酶原时间prothrombin time(PT)胚胎干细胞embryonic stem cells(ESCs)皮质下小卒中二级预防研究(Secondary Prevention of Small Subcotical StrokeSPS3)study平滑肌肌动蛋白smooth muscle actin(SMA)评价心脏机械瓣膜置换术后应用达比加群的安全性及药物动力学Ⅱ期临床随机化研究the Randomized,phaseⅡstudy to Evaluate the s Afety andpharmacokinetics of ora L dab IGatran etexilate展开更多
文摘(Prevention Regimen for Effectively Avoiding Second StrokesPRo FESS)trial内皮型一氧化氮合酶endothelial nitric oxide synthase(e NOS)内-中膜厚度intima-media thickness(IMT)凝血酶时间thrombin time(TT)凝血酶原时间prothrombin time(PT)胚胎干细胞embryonic stem cells(ESCs)皮质下小卒中二级预防研究(Secondary Prevention of Small Subcotical StrokeSPS3)study平滑肌肌动蛋白smooth muscle actin(SMA)评价心脏机械瓣膜置换术后应用达比加群的安全性及药物动力学Ⅱ期临床随机化研究the Randomized,phaseⅡstudy to Evaluate the s Afety andpharmacokinetics of ora L dab IGatran etexilate